3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Gastrointestinal Stromal Tumors
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Burkitt Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplasms
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Melanoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid
1
Leukemia, Biphenotypic, Acute
1
Hypereosinophilic Syndrome
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Digestive System Neoplasms
1
Congenital Bone Marrow Failure Syndromes
1
Blast Crisis
1
Interventions
Doxorubicin
3
pembrolizumab
2
pazopanib
2
Ifosfamide
2
selinexor
1
peposertib
1
liposomal doxorubicin
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Magnetic Resonance Spectroscopy
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Biopsy
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dermatofibrosarcoma
×
Imatinib Mesylate
×
90 days
×
Clear all
No trials found.